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ibroblast migration depends, in part, on activation of
FAK and cellular interactions with tenascin-C (TN-C).
Consistent with the idea that FAK regulates TN-C,
migration-defective FAK-null cells expressed reduced levels
of TN-C. Furthermore, expression of FAK in FAK-null ﬁbro-
blasts induced TN-C, whereas inhibition of FAK activity in
FAK–wild-type cells had the opposite effect. Paired-related
homeobox 1 (
 
Prx1
 
) encodes a homeobox transcription factor
that induces TN-C by interacting with a binding site within
the TN-C promoter, and it also promotes ﬁbroblast migration.
Therefore, we hypothesized that FAK regulates TN-C by
controlling the DNA-binding activity of Prx1 and/or by
inducing Prx1 expression. Prx1–homeodomain binding site
F
 
complex formation observed with FAK–wild-type ﬁbroblasts
failed to occur in FAK-null ﬁbroblasts, yet expression of
Prx1 in these cells induced TN-C promoter activity. Thus,
FAK is not essential for Prx1 DNA-binding activity. However,
activated FAK was essential for Prx1 expression. Functionally,
Prx1 expression in FAK-null ﬁbroblasts restored their ability
to migrate toward ﬁbronectin, in a manner that depends on
TN-C. These results appear to be relevant in vivo because
Prx1 and TN-C expression levels were reduced in FAK-null
embryos. This paper suggests a model whereby FAK induces
Prx1, and subsequently the formation of a TN-C–enriched
ECM that contributes to ﬁbroblast migration.
 
Introduction
 
FAK is a nonreceptor tyrosine kinase that localizes to focal
adhesions, where it integrates and amplifies signals trans-
duced to the cell interior by adhesion receptors and other
extracellular effectors, including soluble growth factors
(Schaller, 2001; Schwartz and Ginsberg, 2002). Comparison
of FAK–wild-type and -null embryos has provided major
clues regarding the functions of FAK in vivo (Furuta et al.,
1995; Ilic et al., 1995, 1996). Mice lacking both copies of
the 
 
fak
 
 gene die at E8.0–8.5 and exhibit a number of abnor-
malities, including severe morphogenetic defects, evident
primarily in the axial mesodermal tissues and the cardiovascular
system (Furuta et al., 1995). Analyses of cells isolated from
FAK-null embryos suggest that FAK participates in embryo-
genesis not only by controlling cell proliferation and survival
but also via its effects on cellular morphology and migration
(Ilic et al., 1995, 1996; Owen et al., 1999). For example,
cultured FAK-null embryonic fibroblasts possess a larger
number of highly stable focal adhesions, and accordingly,
display a circular morphology and a reduced capacity to
migrate on fibronectin (FN)*-coated surfaces. Stable expression
of activated FAK in FAK-null cells, however, increases cell
spreading and reestablishes migration on FN (Sieg et al.,
1999). In terms of the mechanism whereby FAK controls
cell migration, the most widely accepted paradigm is that ac-
tivated FAK regulates the cycle of assembly and disassembly
of focal adhesions, thereby allowing cells to dynamically interact
with their underlying ECM (Ilic et al., 1997). Another
possibility is that activated FAK controls the expression of ECM
genes and proteins that contribute to a pro-migratory tissue
microenvironment, yet this idea has not been fully explored.
Tenascin-C (TN-C) is an ECM glycoprotein expressed in
developing tissues, as well as within remodeling adult tissues,
such as wounds and tumors (Chiquet-Ehrismann et al.,
1986; Jones and Jones, 2000). Numerous cellular functions
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have been ascribed to TN-C, including the control of cellu-
lar proliferation, apoptosis, and differentiation (Vrucinic-
Filipi and Chiquet-Ehrismann, 1993; Jones and Jones,
2000). Analyses of various cells and tissues have also shown
that TN-C protein, (especially larger splice variants contain-
ing the TnfnA-D domain), is associated with a migratory
phenotype in vivo and in tissue culture (Mackie et al., 1988;
Halfter et al., 1989; Derr et al., 1997; Fischer et al., 1997).
The idea that TN-C promotes cell migration is also sup-
ported by studies demonstrating that extracellular TN-C
disassembles stable focal adhesions (Murphy–Ullrich et al.,
1991; Chung et al., 1996). Furthermore, TN-C is able to re-
duce the strength of cell binding interactions with other
ECM molecules, including FN (Lotz et al., 1989). Also,
TN-C–null mice exhibit wound healing defects (Matsuda
et al., 1999), and in vivo knockdown of TN-C expression
in avian embryos attenuates neural crest cell migration
(Tucker, 2001). Collectively, these and other studies indi-
cate that TN-C represents an ECM constituent that is suit-
ably poised to promote cell migration.
TN-C is induced by many of the same factors that activate
FAK, including soluble growth factors, adhesion molecules,
and biomechanical force (Chiquet-Ehrismann et al., 1995;
Jones et al., 1999; Wang et al., 2001). For the most part, in-
tracellular signals generated by these extracellular stimuli
regulate TN-C expression at the transcriptional level (Chi-
quet-Ehrismann et al., 1995; Jones and Jones, 2000). Identi-
fying transcription factors that control TN-C expression is
therefore critical to understanding the regulation and tissue-
specific functions of TN-C. Paired-related homeobox 1
 
(Prx1)
 
 and 
 
Prx2
 
 encode transcription factors that induce
TN-C gene transcription via their ability to interact with a
homeodomain binding site (HBS) located within the proxi-
mal promoter region of the TN-C gene (Jones et al., 2001;
Norris and Kern, 2001). Prx1 and Prx2 are not only ex-
pressed in the same locations as TN-C during embryogene-
sis and in remodeling adult tissues (Bergwerff et al., 1998;
Jones et al., 2001) but they have also been shown to up-reg-
ulate TN-C gene transcription in response to changes in cell
adhesion to the ECM (Jones et al., 2001). Although these
latter studies indicate that an integrin-dependent signaling
pathway might control TN-C gene transcription via its ef-
fects on Prx proteins, the upstream signaling molecules that
mediate this response have not been identified. Given the
central role that FAK plays in relaying integrin-dependent
signals required for cell migration (Ilic et al., 1997), we hy-
pothesized and showed that FAK controls TN-C–dependent
cell migration via its ability to regulate the function of Prx1.
 
Results
 
Activated FAK is required for expression of the 
pro-migratory ECM protein TN-C
 
To determine whether FAK-dependent fibroblast migration
toward FN relies on cellular interactions with TN-C, hapto-
tactic migration assays were performed. Consistent with pre-
vious studies (Sieg et al., 1999), migration of FAK–wild-type
cells through transwells undercoated with FN was signifi-
cantly greater than that of FAK-null cells (Fig. 1 A, left). To
determine whether TN-C plays a role in this process, FAK–
wild-type fibroblasts were plated onto transwells either in the
presence of an anti–TN-C antibody, or a control IgG. Al-
though antibody treatment did not affect cell adhesion to the
transwell surface (unpublished data), blocking cellular inter-
actions with TN-C significantly reduced fibroblast migration
toward FN (Fig. 1 A, right). It should be noted that the TN-C
antibody did not reduce the relative rate of cell migration to
the levels observed with FAK-null cells, thereby indicating
that FAK-dependent fibroblast migration relies on other
molecules besides TN-C. Nevertheless, these experiments al-
lowed us to hypothesize that FAK regulates fibroblast migra-
tion, at least in part, via its effects on TN-C expression.
RT-PCR using total RNA derived from FAK–wild-type
and -null fibroblasts showed that TN-C mRNA expression
was suppressed in the absence of FAK (Fig. 1 B). Western
analysis and immunofluorescence studies also demonstrated
that FAK–wild-type cells synthesized and deposited large
amounts of extracellular TN-C protein, whereas FAK-null
Figure 1. TN-C expression correlates with FAK. 
(A) FAK–wild-type and -null fibroblasts were 
allowed to migrate toward FN for 3 h (left); *, P   
0.05. FAK–wild-type cells were allowed to migrate 
toward FN for 3 h in the presence of a control IgG 
or an anti–TN-C antibody (right); *, P   0.01. (B) 
Semi-quantitative RT-PCR assays to assess the 
steady-state levels of TN-C and GAPDH mRNA 
levels in FAK–wild-type ( ) and -null fibroblasts 
( ). The number of PCR cycles used to amplify 
TN-C mRNA is indicated. (C) Western immunoblots 
for TN-C (top) and smooth muscle  -actin (bottom) 
in FAK–wild-type ( ) and -null ( ) fibroblasts. 
(D) Photomicrographs showing FAK–wild-type ( ) 
and -null ( ) fibroblasts plated onto FN for 24 h 
after immunostaining for TN-C,  -actin, or vinculin 
(green). Cell nuclei were visualized with DAPI 
(blue). Bar, 30  m.T
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cells expressed greatly reduced levels of TN-C (Fig. 1, C and
D). Although two isoforms of TN-C were abundantly ex-
pressed in FAK–wild-type fibroblasts, the higher molecular
mass 220-kD isoform, which has been functionally linked to
migrating cells, was by far the most evident (Fig. 1 C). Im-
munostaining for 
 
 
 
-actin and vinculin showed that TN-C
expressing FAK–wild-type cells exhibit an elongated and po-
larized morphology, whereas TN-C–deficient FAK-null cells
are circular and harbor a greater number of focal adhesions
(Fig. 1 D). Thus, FAK not only correlates with cell migra-
tion and elongation, but also with TN-C expression.
Next, we determined whether FAK activity is required for
TN-C expression. FAK-null fibroblasts were replated onto
FN after transient transfection with plasmids encoding either
an IL2R-FAK fusion protein (i.e., constitutively active FAK),
or a mutated IL2R-FAK protein (Y
 
397F
 
), in which the SH2
binding site tyrosine has been substituted for phenylalanine
(Tamura et al., 1999). Immunostaining for IL2R-FAK and
TN-C in transfected cells showed that constitutive expression
of wild-type FAK, but not the mutated form, increased extra-
cellular TN-C deposition (Fig. 2 A). In parallel, we examined
TN-C mRNA and protein expression using a FAK-null cell
clone that was engineered to stably express FAK (i.e., DA2
cells; Sieg et al., 1999). The characteristics of DA2 cells have
been described previously in detail (Sieg et al., 1999), includ-
ing their restored ability to migrate toward FN. RT-PCR
(Fig. 2 B) and immunofluorescence (Fig. 2 C) assays showed
that TN-C expression is greater in DA2 fibroblasts than in
controls. However, the basal levels of TN-C expression were
greater in the control cells for DA2 when compared with
FAK-null cells (Fig. 1 B). A possible explanation for this dif-
ference may lie in the fact that DA2 and its control line
represent hygromycin-selected clones. Because nonselected
FAK-null cells are heterogeneous in nature, and they do ex-
press some TN-C, it is possible that clonal selection enriched
for cells expressing higher basal levels of TN-C.
As a corollary to these experiments, FAK–wild-type cells
were replated onto FN after transient transfection with a
c-myc epitope–tagged plasmid encoding FAK-related non-
kinase (FRNK), an endogenous and negative regulator of
FAK activity (Schaller et al., 1993). As expected, immuno-
fluorescence staining for the c-myc/FRNK fusion protein
and activated FAK (using a Y
 
397
 
 phospho-FAK–specific anti-
body) showed that transient expression of FRNK, in 
 
 
 
10%
of the total cell population (unpublished data), suppressed
FAK activity (Fig. 2 D, left, and Fig. 2 E). Moreover, inhib-
iting FAK activity via transient overexpression of FRNK also
reduced TN-C expression (Fig. 2 D, right, and Fig. 2 E), yet
this did not suppress the total levels of FAK protein (Fig. 2
E). These data establish that activated FAK is required for
TN-C expression.
 
Control of TN-C expression and fibroblast migration by 
Prx transcription factors
 
Because FAK is required for TN-C expression and the
paired-related homeobox genes 
 
Prx1
 
 and 
 
Prx2
 
 regulate TN-C
gene transcription via their ability to interact with an HBS
within the TN-C gene promoter, we hypothesized that
FAK-dependent migration toward FN might also rely on
Prx transcription factors. To test this, FAK–wild-type cells
were incubated with FITC-labeled, control, or antisense
morpholino oligonucleotides, designed to specifically inhibit
Prx1 and Prx2 protein expression.
Phase-contrast and fluorescence microscopic imaging of
FAK–wild-type cells demonstrated uptake of control and
antisense oligonucleotides in more than 70% of treated cells
(Fig. 3 A), with no evidence of toxicity (unpublished data).
Because morpholino oligonucleotides affect protein transla-
tion rather than mRNA stability, we next evaluated Prx1
and Prx2 protein levels by Western immunoblotting. Anti-
sense morpholino-treated fibroblasts expressed reduced lev-
els of Prx1 and Prx2 protein, when compared with controls
(Fig. 3 B). It should also be noted that an additional cross-
reactive band was detected in Western blots evaluating Prx1
expression, as reported previously (Chesterman et al., 2001).
Targeted suppression of Prx1 and Prx2 also resulted in
Figure 2.  Activated FAK is required for TN-C 
expression. (A) Immunostaining for wild-type FAK 
fusion protein (left, green), or a kinase-dead FAK 
mutant (Y
397F; right, green), as well as TN-C (red), 
in transiently transfected FAK-null ( ) fibroblasts. 
Nuclei are stained blue with DAPI. Bar, 15  m. 
(B) Semi-quantitative RT-PCR assays to assess the 
steady-state levels of TN-C and GAPDH mRNA 
levels in DA2 and control cells. The number of 
PCR cycles used to amplify TN-C mRNA is indicated. 
(C) Photomicrographs showing DA2 and control 
cells plated onto FN after immunostaining for 
TN-C (red). Cell nuclei were visualized with DAPI 
(blue). Bar, 30  m. (D) Photomicrographs showing 
FAK–wild-type ( ) cells replated onto FN after 
transient transfection with FRNK. Cells in the left 
panel were stained for the c-myc/FRNK fusion 
protein (red) and activated FAK (Y
397 phospho-
FAK–specific antibody; green). Cells in the right 
panel were stained for the c-myc/FRNK fusion 
protein (red) and TN-C (green). Cell nuclei were 
visualized with DAPI (blue). Bar, 30  m. (E) Western 
immunoblotting for FRNK, total FAK, phosphorylated FAK and TN-C in cells transiently transfected with a control vector ( ), or with a 
plasmid encoding a c-myc/FRNK fusion protein ( ).T
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down-regulation of TN-C protein expression, whereas
 
 
 
-actin protein expression remained unchanged (Fig. 3 B).
Having established a system in which expression of Prx1,
Prx2, and TN-C are suppressed, we evaluated cell migration
toward FN. Compared with control oligonucleotide-treated
cells, haptotactic migration was significantly reduced in cul-
tures treated with Prx antisense oligonucleotides (Fig. 3 C),
despite the fact that cell adhesion to the transwell surface
was unaffected (unpublished data). Thus, in addition to
FAK and TN-C, Prx transcription factors are required for fi-
broblast migration toward FN.
 
DNA-binding activity and induction of TN-C by Prx1
 
FAK has been shown to promote the DNA-binding activity
of the transcriptional effector STAT1, which in turn en-
hances fibroblast migration via its effect on gene transcrip-
tion (Xie et al., 2001). To determine whether activated FAK
promotes TN-C gene expression via its effect on Prx tran-
scription factor binding to the TN-C gene promoter HBS,
electrophoretic mobility shift assays (EMSAs) were per-
formed. These experiments were also conducted in order to
determine whether Prx1, Prx2, or a combination of both
transcription factors, participate in FAK-dependent induc-
tion of TN-C gene expression.
FAK–wild-type fibroblast nuclear extracts incubated with
a radiolabeled wild-type HBS probe formed three distinct
DNA–protein complexes in EMSAs (Fig. 4 A, lane 2),
whereas incubation of FAK–wild-type nuclear extracts with
the mutated HBS probe failed to support complex forma-
tion (Fig. 4 A, lane 1). Similarly, DNA–protein complex
formation did not occur when the wild-type or mutated
HBS were incubated with nuclear extracts derived from
FAK-null cells (Fig. 4 A, lanes 6 and 7). To determine
whether Prx proteins were present in DNA–protein com-
plexes, the wild-type probe and FAK–wild-type nuclear ex-
tracts were incubated with antibodies that recognize either
Prx1 or Prx2. Treatment with the Prx1 antibody resulted in
an almost complete disruption of the DNA–protein com-
plexes (Fig. 4 A, lane 3), whereas incubation with the anti-
Prx2 antibody, or a control IgG, had no effect (Fig. 4 A,
lanes 4 and 5). These experiments demonstrate that Prx1
protein binding to the HBS fails to occur in the absence of
FAK, and indicate that Prx2 does not interact with the HBS
in vitro, and is therefore unlikely to be a constituent of the
FAK signaling pathway controlling TN-C expression in fi-
broblasts.
Having established that Prx1 interacts with the HBS in
FAK–wild-type cells, we assessed whether exogenous Prx1
protein is able to bind to the HBS in the absence of FAK.
Accordingly, in vitro transcribed/translated, recombinant rat
Prx1 (rPrx1) protein was incubated with the wild-type HBS
in the absence of nuclear extracts. As a control for protein
binding specificity, recombinant RhoA (rRhoA) protein was
incubated with the wild-type HBS probe. rPrx1 interacted
with the HBS (Fig. 4 A, lane 8), whereas rRhoA failed to
bind (unpublished data). Moreover, inclusion of Prx1 anti-
body in these EMSAs confirmed that rPrx1 was present in
the DNA–protein complexes (Fig. 4 A, lane 9). In contrast,
a control IgG did not perturb complex formation (Fig. 4 A,
lane 10). Although these data do not exclude the possibility
that FAK modulates Prx1 binding to the HBS in vivo, they
do indicate that Prx1 is able to bind to the HBS without
FAK, and that FAK might control Prx1 function in an alter-
native manner. Also, when compared with EMSAs per-
formed using FAK–wild-type nuclear extracts, only two ma-
jor complexes were detected in EMSAs involving rPrx1.
Most likely, this is because mouse cells and tissues express
two Prx1 isoforms, designated Prx1a and Prx1b (Fig. 2 A;
Chesterman et al., 2001). Furthermore, the appearance of
two complexes using rPRx1 is likely due to premature trans-
lation termination, or initiation at a downstream methio-
nine.
Because FAK is not essential for Prx1 protein binding to
the HBS in vitro, we next wanted to determine whether
Figure 3.  Paired-related homeobox genes regulate 
TN-C and fibroblast migration. (A) Representative 
phase-contrast (top) and fluorescence (bottom) micro-
graphs showing FAK–wild-type cells treated with 
FITC-labeled control or Prx1 and Prx2 antisense (AS) 
oligonucleotides. Bar, 30  m. (B) Western immuno-
blotting for Prx1, Prx2, TN-C, and  -actin in control 
and AS oligonucleotide–treated FAK–wild-type fibro-
blasts. The anti–Prx1 antibody recognizes two iso-
forms designated Prx1a and Prx1b. An additional 
cross-reactive band was also detected in both samples, 
as reported previously (Chesterman et al., 2001). (C) 
Haptotactic migration assays were used to evaluate 
fibroblast migration toward FN in control and AS-treated 
cells. Shown is relative cell migration between
groups   SEM of triplicates from at least three
independent experiments. *, P   0.05.T
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Prx1 was able to transactivate the TN-C gene promoter in
FAK-null cells. Accordingly, both FAK–wild-type or -null
cells were cotransfected with a TN-C promoter/luciferase
gene reporter plasmid that harbors the HBS, together with
HA epitope-tagged Prx expression vectors, or an empty HA
expression vector as a control. A 
 
 
 
-galactosidase expression
vector was also included to account for transfection effi-
ciency. TN-C gene promoter activity was greater in FAK–
wild-type versus -null cells transfected with the control vec-
tor (Fig. 4 B), raising the possibility that FAK-null cells
might express less endogenous Prx1 protein compared with
FAK–wild-type cells. In addition, Prx1 expression signifi-
cantly increased TN-C gene promoter activity in both FAK–
wild-type and -null cells, when compared with the control
vector (Fig. 4 B). On the other hand, transfection of FAK–
wild-type and -null cells with the Prx2 vector alone had no
effect on basal levels of TN-C promoter activity observed in
control-transfected cultures (Fig. 4 B). Similarly, cotransfec-
tion of Prx1 and Prx2 did not increase the levels of promoter
activity recorded in cells transfected with Prx1 alone (Fig. 4
B). Therefore, consistent with the EMSA experiments, Prx1
is able to function independently of FAK, and it appears to
be the predominant Prx transcription factor involved in the
control of TN-C expression in fibroblasts.
 
FAK is required for Prx1 expression
 
To determine whether FAK regulates TN-C by inducing ex-
pression of Prx1, we conducted RT-PCR assays using total
RNA isolated from FAK–wild-type and -null fibroblasts,
which showed that the steady-state levels of Prx1 mRNA are
suppressed in FAK-null cells (Fig. 5 A). Consistent with this,
Western immunoblotting showed that expression of Prx1a
and Prx1b was suppressed in FAK-null cells (Fig. 5 B). Next,
we directly determined whether FAK is required for Prx1 ex-
pression. It has been reported previously that although the
Prx1 antibody recognizes a cross-reactive band in Western
immunoblots, this antibody specifically recognizes Prx1
when used for immunocytochemistry (Chesterman et al.,
2001). Immunostaining experiments confirmed that FAK-
null cells do not express Prx1 protein (Fig. 5 C, left),
whereas FAK-null cells transiently transfected with the plas-
mid encoding the IL2R-FAK wild-type fusion protein
expressed Prx1 protein in their nuclei (Fig. 5 C, right). RT-
PCR and immunofluorescence experiments using the FAK-
reconstituted DA2 clone also showed that FAK is required
for Prx1 mRNA, and protein expression (Fig. 5, D and E).
As with TN-C mRNA expression, basal levels of Prx1 ex-
pression were greater in control cells for DA2 (Fig. 5 A),
when compared with FAK-null cells.
To ascertain whether activated FAK is required for
Prx1 expression, FAK–wild-type fibroblasts were transiently
transfected with the myc-tagged FRNK expression vector.
Immunostaining experiments showed that FAK–wild-type
cells express nuclear Prx1 protein (Fig. 5 F, left), whereas
overexpression of the myc-FRNK fusion protein reduced the
appearance of Prx1 in the nucleus (Fig. 5 F, right). To-
gether, these studies show that activated FAK is also required
for Prx1 expression.
 
Prx1 expression promotes TN-C–dependent migration 
in FAK-null fibroblasts
 
The aforementioned studies indicate that FAK-dependent
induction of Prx1 activates TN-C gene transcription, and
subsequently the formation of a TN-C–enriched ECM that
conceivably supports cell migration on FN. To determine
whether Prx1 acts downstream from FAK in promoting
TN-C–dependent migration toward FN, we transiently
transfected FAK-null fibroblasts with either a control HA
vector or the HA-tagged Prx1 plasmid, together with a
 
 
 
-galactosidase expression construct. Transfection efficiency
Figure 4.  Prx1 interactions with the HBS and up-regulation of 
TN-C. (A) EMSAs using FAK–wild-type ( ) and -null ( ) fibroblast 
nuclear extracts, incubated with either a radiolabeled wild-type (W) 
or mutated (M) HBS probe. To determine the presence of Prx proteins 
in binding complexes, the wild-type probe and FAK–wild-type 
nuclear extracts were incubated with antibodies that recognize 
Prx1, Prx2, or a control IgG. In separate experiments, in vitro 
transcribed/translated, recombinant rPrx1 protein was incubated 
with the wild-type–HBS in the absence of nuclear extracts. These 
complexes were also treated with an anti–Prx1 antisera or a control 
IgG. (B) TN-C promoter/luciferase gene reporter assays in FAK–
wild-type ( ) or –null ( ) cells cotransfected with a TN-C promoter/
luciferase gene reporter and HA epitope-tagged Prx expression 
vectors (i.e., HA-Prx1, HA-Prx2, or a combination of both). A 
 -galactosidase expression vector was included in each transfection 
to normalize for transfection efficiency. Shown is the relative fold 
increase in TN-C promoter activity   SEM of triplicates from at least 
three independent experiments. *, P   0.05 between all groups. 
#, P   0.05 between HA vector alone transfected into FAK-wild
versus -null cells.T
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was the same in all cells (unpublished data). Thereafter,
transfected cells were replated onto transwells undercoated
with FN, either in the presence of a control IgG, or an anti–
TN-C antibody. Antibody treatment had no effect on cell
adhesion to the transwell surface. In IgG-treated cultures,
Prx1 expression in FAK-null cells promoted cell migration
toward FN compared with control-transfected cells (Fig. 6
A), whereas the anti–TN-C antibody significantly inhibited
this effect (Fig. 6 A).
In keeping with a role for Prx1 in supporting fibroblast
migration via the induction of TN-C, immunostaining ex-
periments showed that FAK-null cells transfected with an
HA-Prx1 expression vector not only expressed TN-C pro-
tein, but that this led to the acquisition of a more elongated
cell morphology on FN (Fig. 6 B). Also, chronic adhesion
(i.e., 24 h) of FAK-null fibroblasts to TN-C resulted in a
loss of cortical actin around the cell perimeter, as well as the
formation of numerous, small focal adhesions, identified
through vinculin staining (Fig. 6 C). Together, these studies
establish that Prx1 and TN-C promote fibroblast migration
toward FN, and that both genes function downstream from
FAK in regulating fibroblast migration.
Having shown that TN-C is necessary for Prx1-dependent
FAK-null fibroblast migration toward FN, we next deter-
Figure 5.  Prx1 expression depends on activated 
FAK. (A) Semi-quantitative RT-PCR assays to assess 
steady-state levels of Prx1 and GAPDH in FAK–
wild-type ( ) and -null ( ) fibroblasts. The number 
of PCR cycles used to amplify Prx1 mRNA is indi-
cated. (B) Western immunoblots for Prx1a and 
Prx1b (top) and  -actin (bottom) in FAK–wild-type 
( ) and -null ( ) fibroblasts. An additional cross-
reactive band was also detected in both samples. 
(C) Representative fluorescence micrographs 
assessing Prx1 immunoreactivity in FAK-null ( ) 
fibroblasts (left), or in FAK-null fibroblasts transiently 
transfected with the IL2R-FAK wild-type fusion 
protein (right). FAK is shown in green, whereas 
Prx1 is shown in red. Nuclei are visualized by 
DAPI staining. Bar, 15  m. (D) Semi-quantitative 
RT-PCR assays were used to assess the steady-state 
levels of Prx1 and GAPDH mRNA levels in DA2 
cells (i.e., FAK-null cells stably transfected with 
FAK) and its control line (i.e., FAK-null cells stably 
transfected with pcDNA3.1). The number of PCR 
cycles used to amplify Prx1 mRNA is indicated. 
(E) Photomicrographs showing DA2 cells and its control line plated onto FN after immunostaining for Prx1 protein (red). Bar, 30  m.
(F) Photomicrographs showing FAK–wild-type ( ) cells replated onto FN followed by immunostaining for Prx1 (left). FAK–wild-type cells 
were transiently transfected with the c-myc/FRNK fusion protein (right), and then stained for FRNK using c-myc antibody (green) and for Prx1 
protein (red). Cell nuclei were visualized with DAPI (blue). Bar, 15  m.
Figure 6.  Prx1 promotes TN-C–dependent 
migration. (A) FAK-null fibroblasts transfected 
with an HA-control or HA-Prx1 expression 
vector were allowed to migrate for 3 h toward 
FN in a transwell migration assay, in the presence 
of control IgG or an anti–TN-C antibody. Trans-
fection efficiency was the same for all cells. 
Shown is the relative cell migration from at least 
three independent experiments; *, P   0.05. 
(B) Representative fluorescence micrograph 
showing Prx1 immunoreactivity in FAK-null 
fibroblasts transiently transfected with the 
HA-Prx1 expression vector. Cells were stained 
for Prx1 via HA (red) and TN-C (green). Nuclei 
are visualized by DAPI staining. Bar, 30  m. 
(C) Immunofluorescence photomicrographs 
showing FAK-null ( ) fibroblasts plated onto 
either FN or TN-C, and then 24 h later immuno-
stained with antibodies recognizing  -actin or 
vinculin (both in green). Cell nuclei were visual-
ized with DAPI (blue). Bar, 20  m. (D) Hapto-
tactic migration assays were used to evaluate 
fibroblast migration toward TN-C or FN in FAK–
wild-type ( ) and -null ( ) fibroblasts. Shown is 
the relative cell migration from at least three 
independent experiments; *, P   0.05.T
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mined whether TN-C is able to rescue FAK-null cells from
their migration defect. Accordingly, FAK–wild-type or -null
cells were plated onto transwells undercoated with TN-C or
FN. No differences in cell adhesion to the surface of the tran-
swells were observed between groups (unpublished data).
Identical to FN, exogenous TN-C protein was unable to res-
cue the FAK-null cell migration defect (Fig. 6 D). Similarly,
replating FAK–wild-type cells treated with Prx1 morpholino
antisense oligonucleotides onto transwells undercoated with
TN-C was also unable to restore FAK-null fibroblast migra-
tion (unpublished data). These experiments indicate that al-
though TN-C is necessary for fibroblast migration, it is not
sufficient. Therefore, FAK and Prx1 likely regulate expres-
sion of other genes required for cell migration.
 
Prx1 and TN-C expression is suppressed 
in FAK-null embryos
 
To determine whether our tissue culture studies were rele-
vant in vivo, we evaluated Prx1 and TN-C expression in
FAK–wild-type and -null mouse embryos, harvested at
E8.5–9.0. Prx1 and TN-C mRNA expression was reduced
in FAK-null embryos compared with their age-matched,
FAK–wild-type counterparts (Fig. 7 A). Parallel immuno-
fluorescence studies of FAK–wild-type and -null embryos
showed that TN-C protein expression is also reduced in
FAK-null embryos (Fig. 7 B). Thus, expression of Prx1 and
TN-C appears to depend on FAK during embryonic devel-
opment.
Because development of FAK-null embryos is delayed
when compared with their wild-type counterparts (Furuta et
al., 1995), we reasoned that this might account for the lower
levels of TN-C and Prx1 expression observed in FAK-null
embryos. However, FN-null embryos, which are also ar-
rested in development and exhibit a phenotype that overlaps
with FAK-null embryos (George et al., 1993), did not show
reduced levels of Prx1 and TN-C mRNA, when compared
with their wild-type counterparts (unpublished data). These
data indicate that Prx1 and TN-C expression levels are re-
duced as a direct result of loss of FAK in vivo.
 
Discussion
 
Many of the intracellular events that regulate fibroblast mi-
gration in response to activation of FAK have been defined,
yet little is known about the transcription factors and target
genes that lie downstream from FAK, and how these might
control cell migration. Here, we showed that FAK is essen-
tial for the expression of Prx1, a transcription factor that ac-
tivates the TN-C gene promoter. Moreover, we have dem-
onstrated that Prx1-dependent induction of TN-C plays a
role in fibroblast migration toward FN.
Although the exact mechanism whereby FAK induces ex-
pression of Prx1 has not yet been elucidated, it is known that
alterations in cell adhesive interactions activate FAK (Ilic et
al., 1997), and induce expression of Prx1 and TN-C (Jones
et al., 1997, 2001). For example, when vascular smooth
muscle cells are cultured on polymeric type I collagen, phos-
phorylation of FAK (unpublished data) and expression of
Prx1 and TN-C is suppressed (Jones et al., 2001), whereas
monomeric type I collagen has the opposite effect. Because
monomeric collagen is predominantly a ligand for 
 
 
 
v
 
 
 
3
 
 inte-
grins (Jones et al., 1997), and blockade of this receptor sup-
presses TN-C gene transcription (Jones et al., 1999), it is
plausible that 
 
 
 
v
 
 
 
3
 
 integrin–dependent activation of FAK
promotes Prx1 expression. A number of FAK-dependent in-
tracellular mediators, including c-src, PI3K, JNK, and ERK
MAPKs, might induce Prx1 gene expression. However, phar-
macological blockade of these signaling effectors in FAK–
wild-type cells appears to have no effect on the steady-state
levels of Prx1 mRNA expression (unpublished data). Ongo-
ing studies will define alternative integrin-activated signaling
mediators that regulate Prx1 gene expression via FAK.
In addition to changes in cell adhesion, alterations in cell
and tissue biomechanics regulate TN-C expression (Chi-
quet-Ehrismann et al., 1994; Jones et al., 1997, 2002).
Given that biological responses to externally applied me-
chanical force appear to be sensed and transduced to the cell
interior by FAK (Wang et al., 2001), it is possible that bio-
mechanical activation of FAK controls TN-C through the
induction of Prx1. In addition to identifying the extrinsic
and intracellular factors that control FAK-dependent induc-
tion of Prx1, it will be necessary to identify the nature of the
transacting factors and cis elements within the Prx1 gene
promoter that might respond to FAK. As stated earlier, Xie
and colleagues (2001) demonstrated that integrins and FAK
control the DNA-binding activity of the transcriptional ef-
fector Stat1. Moreover, FAK-dependent activation of Stat1
resulted in stimulation of cell migration. Because the down-
stream genes regulated in response to FAK-dependent acti-
vation of Stat1 have not yet been identified, it will be of
interest to determine whether Stat1 regulates TN-C by con-
trolling Prx1 expression.
Focal adhesion formation is not only controlled by FAK
but also by the small GTPase Rho (Ridley and Hall, 1992).
Both activation and inactivation of Rho diminishes cell mi-
gration (Takaishi et al., 1993; Ren et al., 2000), suggesting
that FAK controls focal adhesion turnover by modulating
Rho activity. Consistent with this, FAK–wild-type fibro-
blasts transiently reduce Rho activity after initial adhesion
and spreading to FN, whereas FAK-null cells fail to suppress
Figure 7.  Expression of TN-C and Prx1 in FAK-null embryos. (A) 
Semi-quantitative RT-PCR assays to compare the steady-state levels 
of TN-C, Prx1, and  -actin mRNAs in FAK–wild-type ( ) and -null 
( ) E8.5 embryos. (B) Representative fluorescence micrographs 
showing immunostaining of headfold region of FAK–wild-type ( ) 
and -null ( ) E8.5 embryos for TN-C (green). Two different sections 
are shown. Bar, 20  m.T
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Rho activity (Ren et al., 2000). Because TN-C suppresses
Rho activation (Wenk et al., 2000), a tenable working hy-
pothesis is that FAK-dependent induction of TN-C sup-
presses Rho activity in order to facilitate cell spreading and
migration.
Although we showed that exogenous TN-C is unable to
rescue the FAK-null fibroblast migration defect, we were
able to demonstrate that endogenously produced TN-C
plays a role in migration of FAK–wild-type cells toward FN,
as well as for migration of FAK-null cells expressing Prx1.
These data indicate that FAK and Prx1 regulate other pro-
migratory genes besides TN-C. The notion that homeobox
genes simultaneously regulate more than one target gene in-
volved in regulating cell adhesion events is supported by
studies demonstrating that during the invasive stage of an-
giogenesis, HoxD3 is required for expression of the pro-
angiogenic molecules, 
 
 
 
3
 
 integrins, and urokinase plasmino-
gen activator (Boudreau et al., 1997).
Our studies possibly indicate that exogenous TN-C desta-
bilizes focal adhesions in FAK-null fibroblasts. Clearly, this
latter response would not be due to an autocrine loop in-
volving TN-C–dependent activation of FAK. However, in
the absence of FAK, a FAK-related protein tyrosine kinase,
designated Pyk2 is upregulated (Avraham et al., 2000). Per-
haps TN-C controls focal adhesion turnover in FAK-null
cells using Pyk2. In terms of the TN-C cell surface receptors
involved in remodeling focal adhesions, TN-C represents a
ligand for multiple integrins (Jones and Jones, 2000). It has
also been shown that TN-C interacts with cell surface an-
nexin II via the TnfnA-D domain, and that this interaction
perturbs focal adhesion integrity (Chung et al., 1996). Stud-
ies are now under way to identify which TN-C receptors
control focal adhesion turnover in both FAK–wild-type and
-null fibroblasts.
Finally, our tissue culture findings appear to be relevant
to the function of FAK in vivo, given that expression of
Prx1 and TN-C is reduced in FAK-null embryos. How-
ever, Prx1 and TN-C expression levels appear to be rela-
tively higher in FAK-null embryos versus their cultured
counterparts. Therefore, it is possible that nonfibroblast
cell types within the embryo do not rely on FAK to regu-
late Prx1 and TN-C. Alternatively, functional compensa-
tion by FAK-related molecules might account for the
differences observed in vivo and in tissue culture. Microen-
vironmental factors and cell–cell interactions that are lost
in tissue culture might also contribute to differences in
Prx1 and TN-C expression in vivo and in culture. It is also
important to note that although TN-C–null mice exhibit
wound repair defects that likely reflect cell migration defi-
cits (Matsuda et al., 1999), these animals do not pheno-
copy either FAK-null or Prx1-null mice, both of which dis-
play vascular anomalies (Saga et al., 1992; Furuta et al.,
1995; Bergwerff et al., 2000). FAK and/or Prx1-dependent
induction of other pro-migratory ECM proteins that com-
pensate for TN-C might account for these differences. Fu-
ture avenues of investigation examining how FAK controls
signal transduction pathways and gene networks involving
Prx1 and its downstream targets will no doubt shed light
onto how these molecules modulate cell migration in em-
bryonic development and disease.
 
Materials and methods
 
Reagents
 
TN-C and FN protein were purchased from CHEMICON International, Inc.
Type I Collagen was purchased from Cohesion Labs. DME was purchased
from Cellgro. Lipofectamine Plus and Superscript II RT were purchased
from GIBCO BRL. FBS was purchased from Gemini Bio-Products. Ready-
To-Go RT-PCR beads, ECL
 
 
 
 kit, and Vistra Green were purchased from
Amersham Biosciences. Normal goat serum was purchased from Sigma-
Aldrich. PFA was purchased from EMS. Effectene transfection reagent and
Rneasy Mini kits were purchased from QIAGEN. Hematoxylin and
Vectashield mounting medium were purchased from Vector Laboratories.
Rabbit polyclonal 
 
 
 
-Prx1 and  -Prx2 antisera have been described pre-
viously (Chesterman et al., 2001). Mouse mAbs smooth muscle  -actin
(1A4),  –c-myc (9E10),  -vinculin (VIN-11–5), and species-specific HRP-
conjugated secondary antibodies were obtained from Sigma-Aldrich. Rab-
bit polyclonal  -FAK (C-20) and normal rabbit IgG were obtained from
Santa Cruz Biotechnology, Inc. Rabbit polyclonal  -FAK (pY
397) was ob-
tained from Biosource International. Rat monoclonal  -HA (3F10) was ob-
tained from Roche. Mouse monoclonal  –IL-2 receptor (7G7/B6) was
obtained from Upstate Biotechnology. Rabbit polyclonal  -chicken TN-C
antibody was obtained from CHEMICON International, Inc. Goat  -rabbit
(Alexa 488– and rhodamine-conjugated) and goat  -mouse (Alexa 488–
and rhodamine-conjugated) were obtained from Molecular Probes. Goat
 -rat (Cy 3–conjugated) was obtained from Jackson ImmunoResearch Lab-
oratories. Goat  -rat (Texas red–conjugated) was obtained from Vector
Laboratories.
CMV-promoter–driven dominant negative IL2R-FAK
Y397F and constitu-
tively active IL2R-FAK were a gift from Dr. K.M. Yamada (National Insti-
tutes of Health [NIH], Bethesda, MD) to Dr. M. Weiser-Evans. pCMV-
mycFRNK was a gift from Dr. J.T. Parsons (University of Virginia, Char-
lottesville, VA) to Dr. M. Weiser-Evans. TN7, a TN-C promoter construct li-
gated into a promoter-less PA3-Luc vector has been described previously
(Jones et al., 2001). pCMV-HA was obtained from CLONTECH Laborato-
ries, Inc. Rhox-14 (pCMV-HA) and Prx2–14 (pCMV-HA) were generated
by EcoRI digestion of myc-tagged Prx1 and Prx2 expression vectors (Jones
et al., 2001), subcloning into pBluescript SK (Stratagene), followed by KpnI
and partial NotI digestion, and then ligation into NotI–KpnI digested
pCMV-HA.
Cell culture and transfection assays
All cell lines were routinely maintained in complete DME supplemented
with 4 mM L-glutamine, 100  M NEAAs, 100 U/ml P/S plus 10% FBS.
FAK–wild-type and -null fibroblasts were derived from E8.5 mice (Ilic et
al., 1995). Both cell lines carry mutations in the p53 gene introduced by
crossing heterozygous mice for FAK and p53 alleles (Furuta et al., 1995).
DA2 represents a clone of FAK-null cells that were stably transfected with
pcDNA3.1 HA-tagged FAK, whereas the control line represents FAK-null
cells stably transfected with pcDNA3.1 empty vector (Sieg et al., 1999).
Plasmids IL2R-FAK
Y397F, IL2R-FAK, pCMV-mycFRNK, or pCMV-myc
were transfected into either FAK–wild-type or -null fibroblasts using Effect-
ene transfection reagent, whereas Rhox-14 (i.e., Prx1 cDNA), Prx2–14,
pCMV-HA, and pCMV– -galactosidase were transfected into FAK-null fi-
broblasts using Lipofectamine plus. For luciferase assays, FAK–wild-type
and -null fibroblasts were transfected via electroporation (geneZAPPER; IBI)
with 2  g TN7 plasmid, 2  g pCMV– -galactosidase, and either 4  g
pCMV-HA, or 2  g of both Rhox-14 and pCMV-HA, or 2  g of both Prx2–
14 and pCMV-HA, or 2  g of both Rhox-14 and Prx2–14. Cells were trans-
fected in complete DME plus 10% FBS, before being replated. Media were
changed to complete DME plus 2% FBS for 48 h, and then extracts were
prepared in reporter lysis buffer containing protease inhibitors. Luciferase
activity and/or  -galactosidase activity were determined to evaluate TN-C
promoter activity or transfection efficiency, respectively (Jones et al., 2001).
Antisense morpholino oligonucleotides
FITC-labeled antisense Prx1 (5 -GAACGTGCCCGTAGCTGGAGGTCAT-
3 ), antisense Prx2 (5 -GGCCGCGCTGTCCATGCCCTGGC-3 ), and con-
trol (5 -CCTCTTACCTCAGTTACAATTTATA-3 ) morpholinos were pur-
chased from Gene Tools LLC. 3.6 nM morpholinos were delivered to cells
cultured in 35-mm-diam tissue culture dishes in the presence of 1.45  M
EPEI special delivery solution (Gene Tools LLC) in complete DME. After in-
cubating at 37 C for 3 h, media were changed to complete DME plus 10%
FBS for 24 h. Thereafter, cells were serum-starved before using in subse-
quent assays. Uptake of FITC-labeled oligonucleotides was assessed using
an (Axiovert; Carl Zeiss MicroImaging, Inc.) inverted fluorescence micro-
scope with appropriate FITC filters.T
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Western immunoblotting
Protein extracts were prepared in 1  RIPA buffer or 1  cell lysis buffer
(Cell Signaling) and total protein quantified using a Bio-Rad assay. Samples
were separated on 8–16% polyacrylamide gels, transferred to polyvinyldi-
fluoride membranes, which were blocked in wash buffer (10 mM Tris, pH
8, 150 mM NaCl, and 0.1% Tween 20) plus 5% milk. Blots were incu-
bated with primary antibodies (1.16  g/ml  –TN-C, 0.81  g/ml  -Prx1,
0.252  g/ml  -Prx2, 2.93  g/ml  –  smooth muscle actin, 1  g/ml  -FAK,
0.35  g/ml  –pY
397-FAK, and 1:100  –c-myc [for FRNK]) in wash buffer
plus 5% milk, rinsed in wash buffer, and incubated with HRP-conjugated
secondary antibody (1:5,000). Proteins were detected using an ECL  kit.
Immunostaining
Cells were fixed with 4% PFA in PBS. Embryos were fixed in 4% PFA, and
then embedded and frozen in OCT media. 5- m frozen embryonic sec-
tions were fixed after in 4% PFA before immunostaining. All cells and tis-
sues were rinsed in PBS, and permeabilized in PBS containing 0.1% Triton
X-100, before being blocked in 10% normal goat serum in PBSA (PBS plus
0.1% BSA), and incubated with primary antibodies in wash buffer. After
addition of primary antibodies (1.16  g/ml  –TN-C, 22  g/ml  –  smooth
muscle actin, 30  g/ml  -vinculin, 1:100  –c-myc, 0.81  g/ml  -Prx1, 2.5
 g/ml  -HA, 16.7  g/ml  -IL2R, 2  g/ml  -FAK, and 3.5  g/ml  –pY
397-
FAK), samples were rinsed with PBSA, followed by incubation with spe-
cies-specific fluorescein- or Texas red–conjugated antibodies (Molecular
Probes, Inc.), diluted 1:100 in wash buffer. Slides were rinsed in PBS, be-
fore being mounted in Vectashield medium containing DAPI. Specimens
were visualized using an inverted fluorescence microscope.
Semi-quantitative RT-PCR
First strand cDNA was synthesized from total RNA using Superscript II. A
typical 25- l PCR reaction contained one RT-PCR bead, 1  l cDNA, and
0.33   M of each of the following primers: Prx1, 5 -ACCTCCAGC-
TACGGGCACGTT-3  and 5 -ATGGCTCGCTCATTCCTGCGGAA-3  (for
23, 25, or 27 cycles); TN-C, 5 -GGAGTTGCTGGTATCGTCTCTAAGG-3 
and 5 -ACACCTGCCATCCAAACACATC-3  (for 20, 22, or 24 cycles);
 -actin, 5 -CATCCGTAAAGACCTCTATGCCAAC-3  and 5 -CAAAGAAA-
GGGTGTAAAACGCAGC-3  (for 15 cycles); and GAPDH, 5 -TGGGGC-
CAAAAGGGTCATCATCTC-3  and 5 -GCCGCCTGCTTCACCACCTTCTT-
3  (for 18, 20, or 22 cycles). PCR reaction conditions were as follows: 94 C
for 1 min, 59.2 C (GAPDH) or 58.1 C (all others) for 1 min, and then 72 C
for 1 min. Products were separated on 1–1.4% agarose/1  TBE gels con-
taining Vistra Green (1:10,000), and were visualized using a Storm 860
scanner, and quantified with Imagequant software.
Electrophoretic mobility shift assays
Nuclear extracts were prepared using a nuclear extract kit (Activemotif). A
wild-type probe (5 -CGAGTTAATTAACCTGC-3  and 5 -GCAGGTTAAT-
TAACTCG-3 ) containing the Prx HBS (underlined), and mutant probe (5 -
CGAGTTAACTCACCTGC-3  and 5 -GCAGGTGAGTTAACTCG-3 ) were
annealed, gel purified, then   = [
32P]ATP (PerkinElmer) end-labeled by
polynucleotide kinase (Roche). 6  g nuclear extract was mixed with
25,000 cpm probe in 4% Ficoll, 100 mM KCl, 12 mM HEPES, 0.05% NP-
40, 50  g/ml BSA, 37.5  g/ml dIdC at 37 C for 1 h. Where indicated, 2  l
of recombinant Prx1 protein (generated with TNT-coupled Wheat Germ
Extract System; Promega) was added before incubation. Where indicated,
antibodies were added (100 ng  -Prx1,  -Prx2, or normal rabbit IgG), 30
min after the reaction was initiated. Samples were loaded directly onto a
10% native polyacrylamide gel and electrophoresed at 45 mA for 2 h. Gels
were exposed and scanned using a Storm 860 scanner.
Haptotactic migration assays
Transwell chambers (8- m-diam pore size; Corning) were prepared by
precoating the under surface of the polycarbonate membrane with 10  g/
ml FN protein in PBS for 2 h at 37 C. FAK–wild-type and -null cells were
serum-starved (complete DME plus 0.5% FBS) for 48 h, before being
plated onto transwells (Sieg et al., 1999). Transiently transfected and mor-
pholino-treated cells were maintained in complete DME plus 10% FBS (no
P/S) for 36 h after transfection, before 48-h serum starvation. 30,000 cells
(in complete DME plus 0.5% BSA) were added to PBS-washed upper
chambers of the transwell and were incubated for 3 h at 37 C. Where indi-
cated, normal rabbit IgG (DakoCytomation) or  –TN-C Ab (both at 20  g/
ml) were included in the culture media. Cells were fixed in 4% PFA, and
then stained with hemotoxylin. Cells on the upper surface of the mem-
brane were removed with a cotton tip applicator. Cells on the lower sur-
face were counted using phase microscopy. A minimum of three randomly
chosen fields was counted per transwell, and a minimum of three tran-
swells was used for each experimental group. All experiments were per-
formed in triplicate.
FAK–wild-type and -null embryos
Heterozygous lines of FAK and FN mice were housed and bred in an envi-
ronmentally controlled room at the UCSF according to institutional guide-
lines. Genotypes were determined by PCR analysis (Furuta et al., 1995).
Embryos were isolated at E8.5. Placental cone and yolk sac were used for
genotyping, and the embryos were either snap frozen and kept at  80 C
for RT-PCR analyses, or fixed in 3.8% PFA/PBS overnight at 4 C, for immu-
nostaining. Fixed embryos were washed three times in PBS, infiltrated with
5–15% sucrose followed by OCT compound (Miles Scientific), and frozen
in liquid nitrogen. 5- m thick sections were prepared using a cryostat (Slee
International, Inc.).
Statistics
All statistical assessments were compared by one-way analysis of var-
iance (ANOVA) and ANOVA post-hoc analysis using Statview. P  
0.05  was considered statistically significant. Values were presented as
means   SEM.
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